Andrusiewicz M, Szczerba A, Wolun-Cholewa M, Warchol W, Nowak-Markwitz E, Gasiorowska E, Adamska K, Jankowska A (2011) CGB and GNRH1 expression analysis as a method of tumor cells metastatic spread detection in patients with gynecological malignances. J Transl Med 9: 130. [PubMed]
Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14: 146-149.
Attard G, Crespo M, Lim AC, Pope L, Zivi A, De Bono JS (2011) Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative- letter. Clin Cancer Res 17: 3048-3049. [CrossRef]
Ballestrero A, Garuti A, Bertolotto M, Rocco I, Boy D, Nencioni A, Ottonello L, Patrone F (2005) Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer 92: 1948-1952. [PubMed] [CrossRef]
Beeton C, Chandy KG (2007) Enrichment of NK cells from human blood with the rosettesep kit from stemcell technologies. J Vis Exp 8: 326. [PubMed]
Berezovskaya O, Schimmer AD, Glinski AB, Pinilla C, Hoffman RM, Reed JC, Glinsky GV (2005) Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 65: 2378-2386. [PubMed] [CrossRef]
Breen M (2009) Update on genomics in veterinary oncology. Top In Companion Anim Med 24: 113-121.
Chang YS, DI Tomaso E, Mcdonald DM, Jones R, Jain RK, Munn LL (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97: 14608-14613. [CrossRef]
Chu LL, Rutteman GR, Kong JM, Ghahremani M, Schmeing M, Misdorp W, Van Garderen E, Pelletier J (1998) Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia. Breast Cancer Res Treat 50: 11-25.
Crisan D, Ruark DS, Decker DA, Drevon AM, Dicarlo RG (2000) Detection of circulating epithelial cells after surgery for benign breast disease. Mol Diagn 5: 33-38. [PubMed]
DA Costa A, Lenze D, Hummel M, Kohn B, Gruber AD, Klopfleisch R (2012) Identification of six potential markers for the detection of circulating canine mammary tumour cells in the peripheral blood identified by microarray analysis. J Comp Pathol 146: 143-151. [CrossRef]
DA Cunha Santos G, Shepherd FA, Tsao MS (2011) EGFR mutations and lung cancer. Annu Rev Pathol 6: 49-69. [CrossRef]
Devriese LA, Bosma AJ, Van De Heuvel MM, Heemsbergen W, Voest EE, Schellens JH (2011) Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer 75: 242-247 [PubMed]
Fehm T, Muller V, Aktas B, Janni W, Schneeweiss A, Stickeler E, Lattrich C, Lohberg Cr, Solomayer E, Rack B, Riethdorf S, Klein C, Schindlbeck C, Brocker K, Kasimir-Bauer S, Wallwiener D, Pantel K (2010) HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat 124: 403-412. [CrossRef]
Fuse N (2011) Relation of HER2 status and prognosis in gastric cancer patients. Gan To Kagaku Ryoho 38: 1073-1078.
Gama A, Alves A, Schmitt F (2010) Expression and prognostic significance of CK19 in canine malignant mammary tumours. Vet J 184: 45-51. [CrossRef]
Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR (2003) Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 162: 149-155.
Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD (1998) Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17: 89-97. [CrossRef] [PubMed]
Giangreco A, Lu L, Vickers C, Teixeira VH, Groot KR, Butler CR, Ilieva EV, George PJ, Nicholson AG, Sage EK, Watt FM, Janes SM (2011) β-catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial- mesenchymal transition. J Pathol 226: 575-587
Gilbertson SR, Kurzman ID, Zachrau RE, Hurvitz AI, Black MM (1983) Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Vet Pathol 20: 127-142. [PubMed]
Glickman LT, Schofer FS, Mckee LJ, Reif JS, Goldschmidt MH (1989) Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health 28: 407-414. [CrossRef] [PubMed]
Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ, Quinn TP (2003) Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 63: 3805-3811. [PubMed]
Hayes HM, Tarone RE, Cantor KP (1995) On the association between canine malignant lymphoma and opportunity for exposure to 2,4-dichlorophenoxyacetic acid. Environ Res 70: 119-125. [CrossRef]
He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS (2008) Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer 123: 1968-1973. [PubMed] [CrossRef]
He W, Wang H, Hartmann LC, Cheng JX, Low PS (2007) In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci USA 104: 11760-11765. [CrossRef]
Henry CJ, Brewer WG Jr, Whitley em, Tyler JW, Ogilvie GK, Norris A, Fox LE, Morrison WB, Hammer A, Vail DM, Berg J (2005) Canine digital tumors: a veterinary cooperative oncology group retrospective study ff 64 dogs. J Vet Intern Med 19: 720-724. [CrossRef]
Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68. [CrossRef] [PubMed]
Janjigian YY, Shah MA (2011) Molecularly targeted therapies in advanced gastric cancer. Minerva Gastroenterol Dietol 57: 75-88. [PubMed]
Jonasdottir TJ, Mellersh CS, Moe L, Heggebo R, Gamlem H, Ostrander EA, Lingaas F (2000) Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci USA 97: 4132-4137. [CrossRef]
Knapp DW, Glickman NW, Denicola DB, Bonney PL, Lin TL, Glickman LT (2000) Naturally-occurring canine transitional cell carcinoma of the urinary bladder a relevant model of human invasive bladder cancer. Urol Oncol 5: 47-59. [CrossRef] [PubMed]
Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho My, Chen LB, Lerner RA, Bruce RH (2004) A rare-cell detector for cancer. Proc Natl Acad Sci USA 101: 10501-10504. [CrossRef]
Kruck S, Gakis G, Stenzl A (2011) Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors. Anticancer Res 31: 2053-2057. Kruck S, Gakis G, Stenzl A (2012) Circulating and disseminated tumor cells in the management of advanced prostate cancer. Adv Urol 2012: 135-281.
Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H (1990) Ber-Ep4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43: 213-219. [CrossRef]
Leary AF, Castro DG, Nicholson AG, Ashley S, Wotherspoon A, O’brien ME, Popat S (2011) Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors. Eur J Cancer 48: 61-67. [PubMed]
Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez- Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, Scher HI (2009) Fluorescence In Situ Hybridization Analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res 15: 2091-2097. [CrossRef] [PubMed]
Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F (2005) Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. Ilar J 46: 258-268. [CrossRef] [PubMed]
Loisel S, Ohresser M, Pallardy M, Dayde D, Berthou C, Cartron G, Watier H (2007) Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. Crit Rev Oncol Hematol 62: 34-42. [PubMed] [CrossRef]
Luzzi KJ, Macdonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873.
MacEwen EG (1990) Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 9: 125-136. [CrossRef]
Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377.
Metge BJ, Frost AR, King JA, Dyess DL, Welch DR, Samant RS, Shevde LA (2008) Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin Exp Metastasis 25: 753-763.
Molloy TJ, Devriese LA, Helgason HH, Bosma AJ, Hauptmann M, Voest EE, Schellens JH, Van’t Veer LJ (2011) A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer. Br J Cancer 104: 1913-1919. [CrossRef] [PubMed]
Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239.
Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB, Sehouli J, Reinthaller A, Horvat R, Heinze G, Tong D, Zeillinger R (2010) Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. Bmc Cancer 10: 666. [CrossRef] [PubMed]
Ochiai A (2011) Standardization of evaluation for target molecule in cancer therapy. Gan To Kagaku Ryoho 38: 709-714.
Pang LY, Argyle DJ (2009) Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology. Biochim Biophys Acta 1792: 380-391.
Parker HG, Kim LV, Sutter NB, Carlson S, Lorentzen TD, Malek TB, Johnson GS, Defrance HB, Ostrander EA, Kruglyak L (2004) Genetic structure of the purebred domestic dog. Science 304: 1160-1164.
Pilati P, Mocellin S, Bertazza L, Galdi F, Briarava M, Mammano E, Tessari E, Zavagno G, Nitti D (2011) Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol 19: 402-408. [PubMed]
Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL (2005) Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 11: 3722-3732. [CrossRef] [PubMed]
Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marme F, Sultmann H, Altevogt P (2011) Loss of EPCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol Oncol 122: 437-446. [PubMed] [CrossRef]
Saliba AE, Saias L, Psychari E, Minc N, Simon D, Bidard FC, Mathiot C, Pierga JY, Fraisier V, Salamero J, Saada V, Farace F, Vielh P, Malaquin L, Viovy JL (2010) Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc Natl Acad Sci USA 107: 14524-14529. [CrossRef]
Saloustros E, Perraki M, Apostolaki S, Kallergi G, Xyrafas A, Kalbakis K, Agelaki S, Kalykaki A, Georgoulias V, Mavroudis D (2011) Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse. Breast Cancer Res 10: 13.
Schuberth HJ, Kucinskiene G, Chu RM, Faldyna M (2007) Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes. Vet Immunol Immunopathol 119: 47-55. Schwarzenbach H, Alix-Panabieres C, Muller I, Letang N, Vendrell JP, Rebillard X, Pantel K (2009) Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 15: 1032-1038. [CrossRef]
Switonski M, Szczerbal I, Nowacka J (2004) The dog genome map and its use in mammalian comparative genomics. J Appl Genet 45: 195-214. [PubMed]
Tao M, Ma D, Li Y, Zhou C, Li Y, Zhang Y, Duan W, Xu X, Wang R, Wu L, Liu H (2011) Clinical significance of circulating tumor cells in breast cancer patients. Breast Cancer Res Treat 129: 247-254. [PubMed] [CrossRef]
Weihrauch MR, Skibowski E, Draube A, Geller A, Tesch H, Diehl V, Bohlen H (2002) Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies. Clin Exp Metastasis 19: 617-621. [CrossRef] [PubMed]
Weiner LM, Borghaei H (2006) Targeted therapies in solid tumors: monoclonal antibodies and small molecules. Hum Antibodies 15: 103-111. [PubMed]
Wu TL, Zhang D, Chia JH, Tsao KC, Sun CF, Wu JT (2002) Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321: 77-87.
Wu W, Hu G, Kang N, Jiang J, Yang X (2011) Expression of CK19 mRNA and EGFR mRNA in the peripheral blood and its relationship with lymphatic metastasis in laryngeal carcinoma model. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 25: 501-505.
Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M (2003) Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry A 55: 102-108. [PubMed] [CrossRef]
Polish Journal of Veterinary Sciences
The Journal of Committee of Veterinary Sciences of Polish Academy of Sciences and University of Warmia and Mazury in Olsztyn
IMPACT FACTOR increased in 2015: 0.719
5-year IMPACT FACTOR: 0.738
SCImago Journal Rank (SJR) 2015: 0.334
Source Normalized Impact per Paper (SNIP) 2015: 0.496
Impact per Publication (IPP) 2015: 0.693
The application of circulating tumor cells detecting methods in veterinary oncology
1Department of Animal Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury, Oczapowskiego 13 Bldg. 105J, 10-719 Olsztyn, Poland
2Department of Pathophysiology, Forensic Veterinary and Administration, University of Warmia and Mazury, Oczapowskiego 13, 10-719 Olsztyn, Poland
3Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Warmia and Mazury, Oczapowskiego 14, 10-719 Olsztyn, Poland
4Department of Pathology in Zabrze, Medical University of Silesia, 3 Maja 13/15, 41-800 Zabrze, Poland
This content is open access.
Citation Information: Polish Journal of Veterinary Sciences. Volume 16, Issue 1, Pages 141–151, ISSN (Print) 1505-1773, DOI: 10.2478/pjvs-2013-0022, May 2013
- Published Online:
Cancers are one of the most common diseases affecting dogs. Many of them develop spontaneously and their biology and histopathology shows many similarities to human cancers. What more, it is proved that there are much more analogies in molecular mechanisms of cancer development between these two species. Human oncology is seeking more and more efficient methods for an early disease detection which results directly in the extended life expectancy of patients affected. One of the most modern trends in the diagnosis of cancer is to detect circulating tumor cells (CTC) in the blood of patients. It is known that these cells are responsible for the formation of metastases in distant organs what results in the patient death. Moreover, it’s confirmed that CTC are already present in patients’ bloodstream in the early stages of tumor development. There is no doubt that mechanism of metastasis development in dogs is identical and thus the CTC are also present in their bloodstream. Despite the intense researches there is still no optimal method of isolating cancer cells from the blood where they occur extremely rarely. The purpose of this study is to analyze the implications of the detection methods of tumor cells in the blood in veterinary oncology.